Rocket Lab Bull-Case Target $293 Sparks Debate
Morgan Stanley elevates Rocket Lab's bull-case to $293, underscoring potential upside even as the stock retreats in a...
Determine which no fee travel card is better suited for you. Make the right choice for your travel goals and preferences.
22,600 articlesMorgan Stanley elevates Rocket Lab's bull-case to $293, underscoring potential upside even as the stock retreats in a...
As Rocket Lab nears a pivotal earnings print, investors are quietly growing more bullish. This piece breaks down why ...
CoreWeave delivers a record bookings quarter but sinks on concentration fears, while QQQ holds steady amid AI volatil...
An Oppenheimer upgrade follows Oracle’s dramatic price drop, suggesting patient investors could access a premier grow...
America’s bone health quietly faces a looming $19 billion cost as aging Americans confront fragile bones and rising f...
Yield-focused investors have chased AMDY's eye-catching yield this options strategy promises. Yet the income is volat...
Memory names rebound sharply as AI-driven data-center demand returns, led by Western Digital and Seagate’s roughly 7%...
A leading hedge fund just disclosed a sizable new stake in Disc Medicine. This article breaks down what Disc Medicine...
Boise remains a retirement magnet, but costs have risen. With a $900K pot, a paid-off home, and careful tax and cash-...
The world economic forum head Børge Brende resigned Thursday amid scrutiny over ties to Jeffrey Epstein. An independe...
A 68-year-old investor locks in Social Security and tax moves as markets wobble. The hardest retirement money decisio...
XRP bucked a broad market drift as sentiment surged to a five-week high, even as Bitcoin struggled in a bear market. ...